SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13D/A
Under the Securities Exchange Act of 1934
(Amendment No. 2)
AMERICAN CANNABIS COMPANY,
INC.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
105856108
(CUSIP Number)
Michael Novielli
1110 Rt. 55, Suite 206
LaGrangeville, NY 12540
(845) 575-6770
(Name, Address and Telephone
Number of Person
Authorized to Receive Notices
and Communications)
March 28, 2016
(Date of Event Which Requires
Filing of this Statement)
If the filing person
has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing
this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box [ ].
Note
: Schedules
filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7
for other parties to whom copies are to be sent.
The information required on the remainder of this cover page shall not be deemed to
be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject
to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see
the
Notes).
1
|
NAME OF REPORTING PERSON
Dutchess Opportunity Fund II LP
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
|
3
|
SEC USE ONLY
|
4
|
SOURCE OF FUNDS
WC
|
5
|
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e)
[ ]
|
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
NUMBER
OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
7
|
SOLE VOTING POWER
0
|
8
|
SHARED
VOTING POWER
1,711,200
|
9
|
SOLE
DISPOSITIVE POWER
0
|
10
|
SHARED
DISPOSITIVE POWER
1,711,200
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY REPORTING PERSON
1,711,200
|
12
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES
[ ]
|
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
3.75%*
|
14
|
TYPE OF REPORTING PERSON
PN
|
|
|
|
|
_________________
|
*
|
Based on the 45,642,064 shares of Common
Stock most recently reported by the Company as issued and outstanding, as of April 13,
2016.
|
1
|
NAME OF REPORTING PERSON
Michael Novielli
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
|
3
|
SEC USE ONLY
|
4
|
SOURCE OF FUNDS
WC/AF
|
5
|
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e)
[ ]
|
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
|
NUMBER
OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
7
|
SOLE VOTING POWER
296,278
†
|
8
|
SHARED
VOTING POWER
1,760,948
Ω
|
9
|
SOLE
DISPOSITIVE POWER
296,278
†
|
10
|
SHARED
DISPOSITIVE POWER
1,760,948
Ω
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY REPORTING PERSON
2,057,226
|
12
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES
[ ]
|
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
4.51%*
|
14
|
TYPE OF REPORTING PERSON
IN
|
|
|
|
|
________________
|
*
|
Based on the 45,642,064 shares of Common
Stock most recently reported by the Company as issued and outstanding, as of April 13,
2016.
|
|
†
|
All 296,278 shares of Common Stock
are held in the name of Dutchess Global Strategies Fund LLC, a private investment vehicle.
As the sole Manager, all the shares of Common Stock are beneficially owned solely by
Novielli, who has sole power to vote and to dispose or direct the disposition of the
shares of Common Stock.
|
|
Ω
|
The 1,760,948 shares of Common Stock
are held in the name of Dutchess Opportunities Fund II LLC, Dutchess Advisors LLC, Dutchess
Private Equities Fund Ltd. and Dutchess Private Equities Fund II LP (the “Dutchess
Entities”). As Directors, Managers or Managing Partners, as the case may be, of
the Dutchess Entities, Messrs. Novielli and Leighton may be deemed to be indirect beneficial
owners of the shares of Common Stock directly beneficially owned by the Dutchess Entities,
and both may be deemed to have shared power to vote such shares of Common Stock and shared
power to dispose or direct the disposition of such shares of Common Stock.
|
1
|
NAME OF REPORTING PERSON
Douglas Leighton
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
|
3
|
SEC USE ONLY
|
4
|
SOURCE OF FUNDS
WC/AF
|
5
|
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e)
[ ]
|
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
|
NUMBER
OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
7
|
SOLE VOTING POWER
50,578
†
|
8
|
SHARED
VOTING POWER
1,760,948
Ω
|
9
|
SOLE
DISPOSITIVE POWER
50,578
†
|
10
|
SHARED
DISPOSITIVE POWER
1,760,948
Ω
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY REPORTING PERSON
1,811,526
|
12
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES
[ ]
|
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
3.97%*
|
14
|
TYPE OF REPORTING PERSON
IN
|
|
|
|
|
_________________
|
*
|
Based on the 45,642,064 shares of Common
Stock most recently reported by the Company as issued and outstanding, as of April 13,
2016.
|
|
†
|
All 50,578 shares of Common Stock
are held in the name of Bass Point Capital LLC, a private investment vehicle. As the
sole Manager, all the shares of Common Stock are beneficially owned solely by Leighton,
who has sole power to vote and to dispose or direct the disposition of the shares of
Common Stock.
|
|
Ω
|
The 1,760,948 shares of Common Stock
are held in the name the Dutchess Entities. As Directors, Managers or Managing Partners,
as the case may be, of the Dutchess Entities, Messrs. Novielli and Leighton may be deemed
to be indirect beneficial owners of the shares of Common Stock directly beneficially
owned by the Dutchess Entities, and both may be deemed to have shared power to vote such
shares of Common Stock and shared power to dispose or direct the disposition of such
shares of Common Stock.
|
Item 1. Security and Issuer.
This statement relates to
the common stock, $.00001 par value per share (the “Common Stock”), of American Cannabis Company, Inc., a Delaware
corporation (the “Issuer” or, the “Company”), with its principal executive offices at 5690 Logan St. Unit
A, Denver, Colorado 80216.
Item 2. Identity and Background.
|
(a)
|
This statement on Schedule 13D,
as amended, is being filed by Dutchess Opportunity Fund II LP (“Dutchess II”),
Michael Novielli (“Novielli”) and Douglas Leighton (“Leighton”)
(each a “Reporting Person” and, collectively, the “Reporting Persons”).
Novielli and Leighton are the Directors of Dutchess Opportunity Fund II LP (“Dutchess
II”) and may be deemed indirect beneficial owners of the Common Stock directly
beneficially owned by Dutchess II, pursuant to Section 13(d) of the Securities Exchange
Act of 1934, as amended, and the rules thereunder. Further, Novielli and Leighton are
the Managers of Dutchess Advisors LLC (“Advisors”), the Directors of Dutchess
Private Equities Fund Ltd. (“DPEF”), and the Managing Partners of Equities
Fund II LP (“DPEF II”, together with Dutchess II, Advisors and DPEF, the
“Dutchess Entities”), and thus may be deemed indirect beneficial owners of
the Common Stock directly beneficially owned by Advisors, DPEF and DPEF II. Each of the
Reporting Persons disclaims beneficial ownership of the securities reported herein except
to the extent of its pecuniary interest therein.
|
|
(b)
|
The business addresses of the Reporting
Persons is 50 Commonwealth Avenue, Suite 2, Boston, Massachusetts 02116.
|
|
(c)
|
The Reporting Persons have not,
during the last five years, been convicted in a criminal proceeding (excluding traffic
violations or similar misdemeanors).
|
|
(d)
|
The Reporting Persons have not,
during the last five years, been a party to a civil proceeding of a judicial or administrative
body of competent jurisdiction and as a result of such proceeding was or is subject to
a judgment, decree or final order enjoining future violations of, or prohibiting or mandating
activities subject to, federal or state securities laws or finding any violation with
respect to such laws.
|
|
(e)
|
Dutchess II is a limited partnership
organized under the laws of Delaware. Novielli and Leighton are both citizens of the
United States of America.
|
Item 3. Source and Amount of Funds or Other Consideration.
All purchases of the Common Stock reported
herein, and all purchases of other securities which may from time to time have been converted into Common Stock were made using
working capital of the relevant Reporting Person.
As of the date hereof, Novielli has used approximately
$60,000 of his personal working capital to purchase shares of Common Stock, Leighton has used approximately $10,000 of his personal
working capital to purchase shares of Common Stock, and both Novielli and Leighton have directed the use of approximately $346,524
of working capital of the Dutchess Entities to purchase shares of Common Stock, both directly and through the exercise of certain
debentures held by Dutchess II. As previously disclosed in Item 5 of this Schedule 13D, as amended, certain shares of the Common
Stock were acquired in exchange for other securities of the Company in transactions with the Company or to settle certain previously
contracted debts with the Company.
Except as noted above, no other funds or other
consideration were used in making any purchases of Common Stock.
Item 4. Purpose of Transaction.
Each of the Reporting Persons acquired beneficial ownership of the Common Stock to
which this statement relates for investment purposes. Each of the Reporting Persons may in the future determine to purchase
more Common Stock and/or dispose of Common Stock of the Company in the ordinary course of their investment activities, as
market and other conditions dictate.
Item 5. Interest in Securities of the Issuer.
|
(a)
|
Each Reporting Person’s beneficial
ownership of shares of Common Stock is as follows:
|
|
(i)
|
Novielli beneficially owns 2,057,226
shares of Common Stock, constituting 4.51% of all shares of Common Stock issued and outstanding,
such shares consisting of (1) 296,278 shares of Common Stock held by Dutchess Global
Strategies Fund LLC, (2) 1,711,200 shares of Common Stock beneficially owned by Dutchess
II, (3) 2,952 shares of Common Stock held by Advisors, (4) 45,776 shares of Common Stock
held by DPEF, and (5) 1,020 shares of Common Stock held by DPEF II.
|
|
(ii)
|
Leighton beneficially owns 1,811,526
shares of Common Stock, constituting 3.97% of all shares of Common Stock issued and outstanding,
such shares consisting of (1) 50,578 shares of Common Stock held by Bass Point Capital
LLC, (2) 1,711,200 shares of Common Stock beneficially owned by Dutchess II, (3) 2,952
shares of Common Stock held by Advisors, (4) 45,776 shares of Common Stock held by DPEF,
and (5) 1,020 shares of Common Stock held by DPEF II.
|
|
(iii)
|
Dutchess II beneficially owns 1,711,200
shares of Common Stock, constituting 3.75% of all shares of Common Stock issued and outstanding,
such shares consisting of (1) 1,542,450 shares of Common Stock held by Dutchess II, and
(2) 168,750 shares of Common Stock exercisable by Dutchess II under the Debentures (as
defined below).
|
|
(iv)
|
On May 16, 2014, Dutchess II acquired
$71,500 face value of convertible debentures (the “Debentures”) for a purchase
price of $71,500. On April 11, 2016, the Company and Dutchess II entered into an Amendment
No. 1 to Debenture, solely to extend the date of maturity of the Debenture by two (2)
years, to April 24, 2018. The Debentures are convertible into shares of Common Stock
at a conversion price of $0.08 per share; however, the Debentures are subject to a provision
stating that the holder is not entitled to convert, and that the Company will not permit
such conversion, into that number of shares which, when added to the number of shares
of Common Stock already beneficially owned by the converting party (as such term is defined
under Section 13(d) of the Act and Rule 13d-3 thereunder), would exceed 4.99 percent
of the number of shares of Common Stock then issued and outstanding. Prior to March 28,
2016, Dutchess II beneficially owned in excess of 4.99 percent of the number of shares
of Common Stock issued and outstanding, which made the Debentures unexercisable in the
hands of Dutchess II and were deemed not to be beneficially owned. However, as of March
28, 2016, Dutchess II ceased to hold in excess of 4.99 percent of the number of shares
of Common Stock issued and outstanding, and thus the Debentures became exercisable into
that number of shares which, when added to the number of shares of Common Stock held
by Dutchess, II, would not exceed 4.99 percent of the number of shares of Common Stock
issued and outstanding.
|
On April 14, 2016, Dutchess II converted
the Debentures into 725,000 shares of Common Stock, at the exercise price of $0.08 per share. Presently, Dutchess II may convert
the entire outstanding balance of the Debentures into up to 168,750 shares of Common Stock.
Additional information regarding
the Debentures is provided in the Company’s Current Report on Form 8-K filed with the SEC on May 15, 2014, which is expressly
incorporated by reference herein and made a part hereof.
|
(v)
|
Each percentage ownership of shares
of Common Stock set forth in this statement is based on the 45,642,064 shares of issued
and outstanding Common Stock as of April 13, 2016, as reported by the Company
on its Annual Report on Form 1-K filed with the U.S. Securities and Exchange Commission (the “SEC”) on April 13, 2016.
|
|
(b)
|
Each Reporting Persons has voting
power and dispositive control their shares of Common Stock beneficially owned, as follows:
|
|
(i)
|
Novielli has sole power to vote and
sole power to dispose or direct the disposition over the 296,278 shares of Common Stock
held in the name of Dutchess Global Strategies Fund LLC, a private investment vehicle
the investments in which are beneficially owned solely by Novielli.
|
|
(ii)
|
Leighton has sole power to vote
and sole power to dispose or direct the disposition over the 50,578 shares of Common
Stock held in the name of Bass Point Capital LLC, a private investment vehicle the investments
in which are beneficially owned solely by Leighton.
|
|
(iii)
|
As Directors of Dutchess II, each
of. Novielli and Leighton may be deemed to be indirect beneficial owners of the 1,711,200
shares of Common Stock directly beneficially owned by Dutchess II. As a result, each
of the Reporting Persons may be deemed to have shared power to vote such shares of Common
Stock and shared power to dispose or direct the disposition of such shares of Common
Stock.
|
|
(iv)
|
As Managers of Advisors, each of
Novielli and Leighton may be deemed to be indirect beneficial owners of the 2,952 shares
of Common Stock directly beneficially owned by Advisors. As a result, each of the Reporting
Persons may be deemed to have shared power to vote such shares of Common Stock and shared
power to dispose or direct the disposition of such shares of Common Stock.
|
|
(v)
|
As Directors of DPEF, each of Novielli
and Leighton may be deemed to be indirect beneficial owners of the 45,776 shares of Common
Stock directly beneficially owned by DPEF. As a result, each of the Reporting Persons
may be deemed to have shared power to vote such shares of Common Stock and shared power
to dispose or direct the disposition of such shares of Common Stock.
|
|
(vi)
|
As Managing Partners of DPEF II,
each of Novielli and Leighton may be deemed to be indirect beneficial owners of the 1,020
shares of Common Stock directly beneficially owned by DPEF II. As a result, each of the
Reporting Persons may be deemed to have shared power to vote such shares of Common Stock
and shared power to dispose or direct the disposition of such shares of Common Stock.
|
|
(c)
|
The following transactions involving
Common Stock of the Issuer and effected by the Reporting Persons since their most recent
filing of Schedule 13D, are as follows:
|
|
(i)
|
Between September 3, 2015 and April
28, 2016, Dutchess II sold 2,613,719 shares of Common Stock in a series of open-market
transactions at prices ranging from $0.0806 to $0.2320 per share. The Reporting Persons
undertake to provide upon request to the staff of the SEC, full information regarding
the number of shares sold at each separate price within the ranges set forth above.
|
|
(ii)
|
On April 14, 2016, Dutchess II exercised
the Debenture in part, converting $58,000 of the face value of the Debentures into 725,000
shares of Common Stock at a conversion price of $0.08 per share.
|
|
(iii)
|
Other than the matters referred
to herein, there have been no other transactions in the Common Stock effected by the
Reporting Persons during the sixty days preceding the filing of this statement on Schedule
13D, as amended.
|
|
(d)
|
Except as set forth herein, no
other person is known to have the right to receive or the power to direct the receipt
of dividends from, or any proceeds from the sale of, securities of the Issuer beneficially
owned by the Reporting Persons.
|
|
(e)
|
Each of the following transactions
caused the Reporting Person described therein to cease to be a beneficial owner of more
than five percent (5%) of Common Stock of the Issuer:
|
|
(i)
|
On March 28, 2016, Dutchess II sold
761,934 shares of Common Stock in an open-market transaction at a price per share of
$0.1679, thereby representing a disposition in the aggregate constituting a material
change of shares of Common Stock held since the Reporting Persons’ most recent
filing of a statement on Schedule 13D, and causing Dutchess II’s beneficial ownership
of Common Stock of the Issuer to fall below five percent (5%).
|
|
(ii)
|
On April 19, 2016, Dutchess II sold
93,900 shares of Common Stock in an open-market transaction at a price per share of $0.2320,
thereby causing Leighton’s beneficial ownership of Common Stock of the Issuer to
fall below five percent (5%).
|
|
(iii)
|
On April 21, 2016, Dutchess II
sold 101,868 shares of Common Stock in an open-market transaction at a price per share
of $0.2030, thereby causing Novielli’s beneficial ownership of Common Stock of
the Issuer to fall below five percent (5%).
|
Item 6. Contracts, Arrangements, Understandings or Relationships
with Respect to Securities of the Issuer.
Other than the matters discussed
herein, including but not limited to the matters discussed in Item 5 of this statement on Schedule 13D, as amended, none of the
Reporting Persons has any contracts, arrangements, understandings or relationships (legal or otherwise), including, but not limited
to, transfer or voting of any of the securities, finder’s fees, joint ventures, loan or option arrangements, puts or calls,
guarantees of profits, division of profits or loss, or the giving or withholding of proxies, between such Reporting Person and
any other person, with respect to any securities of the Company, including any securities pledged or otherwise subject to a contingency
the occurrence of which would give another person voting power or investment power over such securities other than standard default
and similar provisions contained in such agreements.
Item 7. Material to Be Filed as Exhibits.
The following documents are filed as exhibits:
Exhibit Ref.
|
|
Description
|
Exhibit A
|
|
Joint Filing Agreement
|
Exhibit B
|
|
Information regarding the Debentures (incorporated herein by reference to the Company’s current report on Form 8-K and related exhibits filed with the SEC on May 15, 2014).
|
SIGNATURES
After reasonable inquiry
and to the best of our knowledge and belief, the undersigned certify that the information set forth in this statement on Schedule
13D, as amended, is true, complete and correct.
Dated: May 3, 2016
DUTCHESS OPPORTUNITY FUND II LP
/s/ Michael Novielli
Name: Michael Novielli
Title: Director
DUTCHESS OPPORTUNITY FUND II LP
/s/ Douglas Leighton
Name: Douglas Leighton
Title: Director
/s/ Michael Novielli
Michael Novielli
/s/ Douglas Leighton
Douglas Leighton
EXHIBIT A TO SCHEDULE 13D/A
May 3, 2016
In accordance with Rule 13d-1(k)(1) under
the Securities Exchange Act of 1934, as amended, DUTCHESS OPPORTUNITY FUND II LP, MICHAEL NOVIELLI and DOUGLAS LEIGHTON hereby
agree to the joint filing of this statement on Schedule 13D (including any and all amendments hereto). In addition, each party
to this Joint Filing Agreement expressly authorizes each other party to this Joint Filing Agreement to file on its behalf any
and all amendments to such statement on Schedule 13D. A copy of this Joint Filing Agreement shall be attached as an exhibit to
the statement on Schedule 13D, as amended, filed on behalf of each of the parties hereto, to which this Joint Filing Agreement
relates.
This Joint Filing Agreement may be executed
in multiple counterparts, each of which shall constitute an original, one and the same instrument.
DUTCHESS OPPORTUNITY FUND II LP
/s/ Michael Novielli
Name: Michael Novielli
Title: Director
DUTCHESS OPPORTUNITY FUND II LP
/s/ Douglas Leighton
Name: Douglas Leighton
Title: Director
/s/ Michael Novielli
Michael Novielli
/s/ Douglas Leighton
Douglas Leighton
American Cannabis (QB) (USOTC:AMMJ)
Historical Stock Chart
From Mar 2024 to Apr 2024
American Cannabis (QB) (USOTC:AMMJ)
Historical Stock Chart
From Apr 2023 to Apr 2024